NCT00530582View on ClinicalTrials.gov

Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

July 31, 2004

Conditions

HealthyPostmenopausal

Interventions

DRUG

progesterone

300mg progesterone /placebo each for 21 days

Trial Locations (1)

80804

Max Planck Institute of Psychiatry, Munich

All Listed Sponsors

collaborator

Dr. Kade/Besins Pharma GmbH, Rigistr. 2, 12277 Berlin

UNKNOWN

lead

Max-Planck-Institute of Psychiatry

OTHER

NCT00530582 - Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women | Biotech Hunter | Biotech Hunter